Pharmacological Impacts of Mucopolysacccharide Polysulfates in the Epidermis Involves Inhibition of Amphiregulin‐Mediated Signals in Keratinocytes
Experimental Dermatology · 2024
DOI: 10.1111/exd.70000 ↗At a glance
Journal article in Experimental Dermatology, 2024. Written by Ryo Hirase and 4 co-authors. Institution: Graduate School of Medicine, Chiba University, Chiba, Japan. Major MEDLINE topics: Amphiregulin, Keratinocytes, Polysaccharides, Phosphates. Cited 3 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
The epidermis, the most superficial layer of the human skin, serves a critical barrier function, protecting the body from external pathogens and allergens. Dysregulation of epidermal differentiation contributes to barrier dysfunction and has been implicated in the pathology of various dermatological diseases, including atopic dermatitis (AD). Mucopolysaccharide polysulphate (MPS) is a moisturising agent used to treat xerosis in patients with AD. However, its mechanism of action on keratinocytes, the main constituents of the epidermis, remains unclear. In this study, we investigated the effect of MPS on keratinocytes by subjecting adult human epidermal and three‐dimensional cultured keratinocytes to MPS treatment, followed by transcriptome analysis. The analysis revealed that MPS treatment enhances keratinocyte differentiation and suppresses proliferation. We focused on amphiregulin (AREG), a membrane protein that belongs to the epidermal growth factor (EGF) family and possesses a heparin‐binding domain, as a significant target among the genes altered by MPS. MPS exerted an inhibitory effect directly on AREG, rather than on EGF receptors or other members of the EGF family. Furthermore, AREG leads to a reduction in epidermal barrier function, whereas MPS contributes to barrier enhancement via AREG inhibition. Collectively, these findings suggest that MPS modulates barrier function through AREG inhibition, offering insights into potential therapeutic strategies for skin barrier restoration.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Graduate School of Medicine, Chiba University, Chiba, Japan.
- Kyoto R&D Center, Maruho Co., Ltd., Kyoto, Japan.
- RIKEN Center for Integrative Medical Sciences (IMS-RCAI), Kanagawa, Japan.
ORCID profiles: Ryo Hirase, Tomohiro Miyai, Hiroshi Kawasaki, Haruhiko Koseki
Cite
APA
Hirase, R., Fujita, T., Miyai, T., Kawasaki, H., & Koseki, H. (2024). Pharmacological Impacts of Mucopolysacccharide Polysulfates in the Epidermis Involves Inhibition of Amphiregulin‐Mediated Signals in Keratinocytes. Experimental Dermatology. https://doi.org/10.1111/exd.70000
Vancouver
Hirase R, Fujita T, Miyai T, Kawasaki H, Koseki H. Pharmacological Impacts of Mucopolysacccharide Polysulfates in the Epidermis Involves Inhibition of Amphiregulin‐Mediated Signals in Keratinocytes. Experimental Dermatology. 2024. doi:10.1111/exd.70000
BibTeX
@article{Hirase2024,
author = {Hirase, Ryo and Fujita, Tomoyuki and Miyai, Tomohiro and Kawasaki, Hiroshi and Koseki, Haruhiko},
title = {Pharmacological Impacts of Mucopolysacccharide Polysulfates in the Epidermis Involves Inhibition of Amphiregulin‐Mediated Signals in Keratinocytes},
journal = {Experimental Dermatology},
year = {2024},
doi = {10.1111/exd.70000}
}
EUVIMED